Report Company Directory

DIFFER GROUP AUTO LIMITED

Differ Group Holding (P Chip)

• Differ Group Auto Limited: 1 director by SmartInsider
• 鼎丰集团控股有限公司（6878.HK）投资意见 by AMC Wanhai Securities Ltd.
• Differ Group Holding Co Ltd (6878.HK) by AMC Wanhai Securities Ltd.
• Ford Equity International Rating and Forecast Report by Ford Equity Research

Differential Brands Group

• Differential Brands Group Announces Largest Brand Extension in Robert Graham’s History, Signs New Licensees in Eyewear, Footwear, Home Furnishings, and Loungewear by BusinessWire
• Differential Brands Group Reports Q4 and Annual 2017 Results by BusinessWire
• Differential Brands Group Partners with Throat Threads Apparel to Relaunch Hudson Jeans in Canada by BusinessWire
• Differential Brands Reports Third Quarter 2017 Results by BusinessWire
• Differential Brands Reports Second Quarter 2017 Results by BusinessWire
• Two Directors bought 30,000 shares at between 1.945USD and 2.082USD. by SmartInsider
• Differential Brands Reports First Quarter 2017 Results by BusinessWire
• Differential Brands Group Names Matthew Fior President of Hudson Jeans by BusinessWire
• Differential Brands Group Reports Fourth Quarter and Fiscal Year 2016 Results by BusinessWire
• Differential Brands Group Inc. to Present at 29th Annual ROTH Conference by BusinessWire

DIFFUSION ENGINEERS LIMITED

Diffusion Pharmaceuticals

• Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma by GlobeNewsWire
• EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative Diseases by GlobeNewsWire
• Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities by GlobeNewsWire
• Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-Dealing by GlobeNewsWire
• Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update by GlobeNewsWire
• Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process by GlobeNewsWire
• Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC by GlobeNewsWire
• Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update by GlobeNewsWire
• Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation by GlobeNewsWire
• Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial by GlobeNewsWire